Effect of a new HMG-CoA reductase inhibitor, atorvastatin, on lipids, apolipoproteins and lipoprotein particles in patients with elevated serum cholesterol and triglyceride levels (Q73589935)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 August 1997

Language	Label	Description	Also known as
English	Effect of a new HMG-CoA reductase inhibitor, atorvastatin, on lipids, apolipoproteins and lipoprotein particles in patients with elevated serum cholesterol and triglyceride levels	scientific article published on 01 August 1997

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9258416%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Effect of a new HMG-CoA reductase inhibitor, atorvastatin, on lipids, apolipoproteins and lipoprotein particles in patients with elevated serum cholesterol and triglyceride levels (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9258416%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

0 references

author name string

P Alaupovic

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9258416%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

T Heinonen

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9258416%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

L Shurzinske

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9258416%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

D M Black

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9258416%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 August 1997

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9258416%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Atherosclerosis

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9258416%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

133

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9258416%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

123-133

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9258416%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9258416%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900119-6

7 January 2021

Comparison of low-dose simvastatin and gemfibrozil in the treatment of elevated plasma cholesterol. A multicenter study. The Simvastatin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900119-6

7 January 2021

Combination drug therapy for familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900119-6

7 January 2021

Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900119-6

7 January 2021

Atorvastatin, a New HMG-CoA Reductase Inhibitor as Monotherapy and Combined With Colestipol

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900119-6

7 January 2021

The lipid-lowering effects of atorvastatin, a new HMG-CoA reductase inhibitor: results of a randomized, double-masked study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900119-6

7 January 2021

Quantitative determination of human apolipoprotein C-III by electroimmunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900119-6

7 January 2021

Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900119-6

7 January 2021

Apolipoprotein composition as the basis for classifying plasma lipoproteins. Characterization of ApoA- and ApoB-containing lipoprotein families

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900119-6

7 January 2021

Effects of lovastatin on ApoA- and ApoB-containing lipoproteins. Families in a subpopulation of patients participating in the Monitored Atherosclerosis Regression Study (MARS).

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900119-6

7 January 2021

Efficacy and safety of a new hydroxymethylglutaryl-coenzyme A reductase inhibitor, atorvastatin, in patients with combined hyperlipidemia: comparison with fenofibrate.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900119-6

7 January 2021

Simvastatin. A review of its pharmacological properties and therapeutic potential in hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900119-6

7 January 2021

The effect of pravastatin on plasma lipoprotein and apolipoprotein levels in primary hypercholesterolemia. The Southeastern Michigan Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900119-6

7 January 2021

Significance of apolipoproteins for structure, function, and classification of plasma lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900119-6

7 January 2021

Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900119-6

7 January 2021

The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900119-6

7 January 2021

Interaction of LpB, LpB:E, LpB:C-III, and LpB:C-III:E lipoproteins with the low density lipoprotein receptor of HeLa cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900119-6

7 January 2021

Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and E

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900119-6

7 January 2021

Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900119-6

7 January 2021

A multicenter comparison of the effects of simvastatin and fenofibrate therapy in severe primary hypercholesterolemia, with particular emphasis on lipoproteins defined by their apolipoprotein composition

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900119-6

7 January 2021

Primary hypertriglyceridemia with borderline high cholesterol and elevated apolipoprotein B concentrations. Comparison of gemfibrozil vs lovastatin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900119-6

7 January 2021

Effects of lovastatin therapy on very-low-density lipoprotein triglyceride metabolism in subjects with combined hyperlipidemia: evidence for reduced assembly and secretion of triglyceride-rich lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900119-6

7 January 2021

Identifiers

10.1016/S0021-9150(97)00119-6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9258416%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9258416%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73589935&oldid=2081941304"